Compounds for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to same

    公开(公告)号:US10265425B2

    公开(公告)日:2019-04-23

    申请号:US15186764

    申请日:2016-06-20

    Applicant: STC.UNM

    Abstract: The present invention is directed to novel non-invasive diagnostic tools/compounds comprising a cyclic peptide wherein the compound binds to a MSH receptor to image and treat cancers, especially, melanoma, including metastatic melanoma in vivo. The present invention represents a clear advance in the art which presently relies on tissue biopsy for diagnoses of these cancers. The novel imaging probes are capable of detecting cancerous melanoma cells, as well as their metastatic spread in tissues. This represents a quantum step forward in the diagnosis and treatment of melanoma, including metastatic melanoma using non-invasive molecular imaging techniques. The novel probes of the present invention will also be useful to initiate therapy for melanoma as well as monitor patients response to chemotherapy treatments and other interventions or therapies used in the treatment of melanoma/metastatic melanoma. Compounds according to the present invention may be used as diagnostic tools for a number of conditions and diseases states as well as therapeutic agents for treating such conditions and disease states.

    Radiolabeled alpha-melanocyte stimulating hormone hybrid peptide for melanoma targeting

    公开(公告)号:US10238758B2

    公开(公告)日:2019-03-26

    申请号:US15261890

    申请日:2016-09-10

    Applicant: STC.UNM

    Inventor: Yubin Miao

    Abstract: The present invention is directed to novel non-invasive diagnostic tools/compounds to image cancers, especially, melanoma, including metastatic melanoma in vivo. The present compounds exhibit enhanced uptake in cancerous cells and tissue, suggesting favorable selective activity of compounds according to the present invention, which can be used as effective therapeutic agents against melanoma, including metastatic melanoma. The compounds according to the present invention represent an advance in the diagnosis and treatment of melanoma, including metastatic melanoma using non-invasive molecular imaging techniques. The novel probes of the present invention are useful to initiate therapy for melanoma as well as monitor patients' response to chemotherapy treatments and other interventions or therapies used in the treatment of melanoma/metastatic melanoma. Compounds according to the present invention may be used as diagnostic and therapeutic tools for a number of conditions and diseases states, especially melanoma.

    SYSTEMS AND METHODS FOR INTEGRATING DISTRIBUTED ENERGY RESOURCES

    公开(公告)号:US20190089161A1

    公开(公告)日:2019-03-21

    申请号:US16186812

    申请日:2018-11-12

    Applicant: STC.UNM

    Abstract: The present invention is an apparatus and method for using aggregated loads from a plurality of distributed energy resources to perform a function at a power distribution feeder. The invention includes a plurality of distributed energy resources, wherein at least one distributed energy resource includes a renewable energy resource, a communication network, a control device, a power distribution feeder coupled to the control device, and an energy storage system coupled to the power distribution feeder. The control device sends a signal to the plurality of distributed energy resources via the communication network. The signal is a request to switch a status of one or more of the distributed energy resources if one or more distributed energy resources is within a predetermined condition. Loads from the one or more of the distributed energy resources that switched status are aggregated to perform a function at the power distribution feeder.

    A PRIVACY-PRESERVING, MUTUAL PUF-BASED AUTHENTICATION PROTOCOL

    公开(公告)号:US20190026457A1

    公开(公告)日:2019-01-24

    申请号:US16067757

    申请日:2017-01-11

    Applicant: STC.UNM

    Abstract: An authentication protocol using a Hardware-Embedded Delay PUF (“HELP”), which derives randomness from within-die path delay variations that occur along the paths within a hardware implementation of a cryptographic primitive, for example, the Advanced Encryption Standard (“AES”) algorithm or Secure Hash Algorithm 3 (“SHA-3”). The digitized timing values which represent the path delays are stored in a database on a secure server (verifier) as an alternative to storing PUF response bitstrings thereby enabling the development of an efficient authentication protocol that provides both privacy and mutual authentication.

    Innovative nanopore sequencing technology

    公开(公告)号:US10184930B2

    公开(公告)日:2019-01-22

    申请号:US15039825

    申请日:2014-11-26

    Applicant: STC.UNM

    Abstract: Methods and apparatus for long read, label-free, optical nanopore long chain molecule sequencing. In general, the present disclosure describes a novel sequencing technology based on the integration of nanochannels to deliver single long-chain molecules with widely spaced (>wavelength), ˜1-nm aperture “tortuous” nanopores that slow translocation sufficiently to provide massively parallel, single base resolution using optical techniques. A novel, directed self-assembly nanofabrication scheme using simple colloidal nanoparticles is used to form the nanopore arrays atop nanochannels that unfold the long chain molecules. At the surface of the nanoparticle array, strongly localized electromagnetic fields in engineered plasmonic/polaritonic structures allow for single base resolution using optical techniques.

Patent Agency Ranking